[Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome]
- PMID: 10204402
[Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome]
Abstract
The special patterns of the slow wave activity in irrittable bowel syndrome by means of surface electromyography were examined and the effect of pinaverium bromide on the symptoms and on the colonic motility in this disease was estimated. Twenty two patients with irritable bowel syndrome and 7 healthy controls were selected to the study. The clinical symptoms were abdominal pain and bloating in all patients, constipation in 9, and diarrhoea in 6 cases. Surface electromyography was carried out before and on the 14th day of the treatment with pinaverium bromide (50 mg t. i. d). The colonic motility was analysed in a 2 hour fasting and a 2 hour postprandial period following a standard (800 kCal) meal. The slow wave frequency of 0.01-0.04 Hz were selected and analysed. The mean frequency of activity peaks (n/10 min) and power-index (area under curve, microV 10 min) were measured. For statistical analysis Student's t-test was applied. Electromyogram of patients with irritable bowel syndrome showed a significant increase of the measured colonic motility parameters both in fasting and postprandial states. Fourteen days of pinaverium bromide treatment was able to significantly reduce the intensity of the colonic motor activity. Administration of pinaverium bromide completely released in 6 and significantly improved the abdominal pain in other 12 patients, while the bloating disappeared in 12 and was significantly improved in 5 from 22 patients. Pinaverium bromide was able to normalise the stool frequency: the weekly number of stools was decreased from 16 to 7 in the patients complaining diarrhoea ant it was increased from 2 to 6 in the patients with constipation.
Similar articles
-
Reduction of post-prandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome.Acta Gastroenterol Latinoam. 1997;27(4):247-51. Acta Gastroenterol Latinoam. 1997. PMID: 9401097 Clinical Trial.
-
Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome.Int J Clin Pharmacol Ther Toxicol. 1989 Jan;27(1):47-50. Int J Clin Pharmacol Ther Toxicol. 1989. PMID: 2744907 Clinical Trial.
-
[Manometric effects of pinaverium bromide in irritable bowel syndrome].Acta Gastroenterol Latinoam. 1992;22(1):37-43. Acta Gastroenterol Latinoam. 1992. PMID: 1295286 Clinical Trial. Spanish.
-
[The clinical pharmacological profile of pinaverium bromide].Minerva Med. 1994 Apr;85(4):179-85. Minerva Med. 1994. PMID: 8028745 Review. Italian.
-
Colonic myoelectric activity in the irritable bowel syndrome.Gastroenterology. 1976 Mar;70(3):326-30. Gastroenterology. 1976. PMID: 765183 Review.
Cited by
-
Role of antispasmodics in the treatment of irritable bowel syndrome.World J Gastroenterol. 2014 May 28;20(20):6031-43. doi: 10.3748/wjg.v20.i20.6031. World J Gastroenterol. 2014. PMID: 24876726 Free PMC article. Review.
-
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3. Cochrane Database Syst Rev. 2011. PMID: 21833945 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical